BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19540985)

  • 1. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema.
    Kumar V; Ghosh B; Goel N
    Am J Ophthalmol; 2009 Jul; 148(1):171; author reply 171-2. PubMed ID: 19540985
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial.
    Maia OO; Takahashi BS; Costa RA; Scott IU; Takahashi WY
    Am J Ophthalmol; 2009 Feb; 147(2):291-297.e2. PubMed ID: 18929352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic macular edema.
    Jonas J; Rensch F
    Ophthalmology; 2009 Mar; 116(3):594-5; author reply 596-7. PubMed ID: 19264219
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic macular edema.
    Gillies M
    Ophthalmology; 2009 Mar; 116(3):595; author reply 596-7. PubMed ID: 19264220
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.
    Faghihi H; Roohipoor R; Mohammadi SF; Hojat-Jalali K; Mirshahi A; Lashay A; Piri N; Faghihi Sh
    Eur J Ophthalmol; 2008; 18(6):941-8. PubMed ID: 18988166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic macular edema.
    Narula R; Agarwal M; Chaudhary SP; Shroff C
    Ophthalmology; 2009 Sep; 116(9):1833-4; author reply 1834. PubMed ID: 19729104
    [No Abstract]   [Full Text] [Related]  

  • 7. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Er H
    Am J Ophthalmol; 2008 Aug; 146(2):332-3; author reply 333. PubMed ID: 18656589
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal triamcinolone.
    Gillies MC; Simpson JM; Zhu M; Hunt G; Ali H; Gaston C
    Ophthalmology; 2009 Mar; 116(3):591. PubMed ID: 19264215
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetic macular edema.
    Kim SJ
    Ophthalmology; 2009 Jun; 116(6):1228.e1; author reply 1228-9. PubMed ID: 19486803
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
    Diabetic Retinopathy Clinical Research Network
    Ophthalmology; 2008 Sep; 115(9):1447-9, 1449.e1-10. PubMed ID: 18662829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DRCR Study: outcomes in focal vs diffuse edema?
    Blanco-Garavito R; Rodriguez-Valdes PJ
    Ophthalmology; 2009 Mar; 116(3):595-6; author reply 596-7. PubMed ID: 19264221
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial.
    Gillies MC; McAllister IL; Zhu M; Wong W; Louis D; Arnold JJ; Wong TY
    Ophthalmology; 2011 May; 118(5):866-72. PubMed ID: 21232801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic macular edema.
    Ghazi NG; Scruggs RT; Batchelet AR; Compton MW; Allam SS; Patrie J; Salti HI
    Ophthalmology; 2012 Dec; 119(12):2643.e1. PubMed ID: 23207021
    [No Abstract]   [Full Text] [Related]  

  • 15. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
    ; Elman MJ; Aiello LP; Beck RW; Bressler NM; Bressler SB; Edwards AR; Ferris FL; Friedman SM; Glassman AR; Miller KM; Scott IU; Stockdale CR; Sun JK
    Ophthalmology; 2010 Jun; 117(6):1064-1077.e35. PubMed ID: 20427088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence.
    Lorenzo-Carrero J
    Retina; 2009 Jun; 29(6):868-9; author reply 869. PubMed ID: 19516126
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy.
    Zacks DN; Johnson MW
    Retina; 2005; 25(2):135-40. PubMed ID: 15689801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.
    Bressler NM; Edwards AR; Beck RW; Flaxel CJ; Glassman AR; Ip MS; Kollman C; Kuppermann BD; Stone TW;
    Arch Ophthalmol; 2009 Dec; 127(12):1566-71. PubMed ID: 20008708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.
    ; Beck RW; Edwards AR; Aiello LP; Bressler NM; Ferris F; Glassman AR; Hartnett E; Ip MS; Kim JE; Kollman C
    Arch Ophthalmol; 2009 Mar; 127(3):245-51. PubMed ID: 19273785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.